Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C6H11NO2S |
| Molecular Weight | 161.222 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H](CSCC=C)C(O)=O
InChI
InChIKey=ZFAHNWWNDFHPOH-YFKPBYRVSA-N
InChI=1S/C6H11NO2S/c1-2-3-10-4-5(7)6(8)9/h2,5H,1,3-4,7H2,(H,8,9)/t5-/m0/s1
| Molecular Formula | C6H11NO2S |
| Molecular Weight | 161.222 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
S-Allylcysteine (SAC), the most abundant organosulfur compound in aged garlic extract, has multifunctional activity via different mechanisms and neuroprotective effects that are exerted probably via its antioxidant or free radical scavenger action. Anticancer effects of SAC were reported in prostate cancer, breast cancer, oral cavity cancer, non-small cell lung cancer, neuroblastoma, and hepatocellular carcinoma through the restoration of E-cadherin, the reduction of Slug and matrix metalloproteinase (MMP) protein expression, and stimulating apoptotic pathways. In addition, recently was revealed, that SAC might have imperative implications for the deterrence and early treatment of type 2 diabetes by reducing the influx of glucose in the polyol pathway, thereby elevating the GSH level and reducing the activities of aldose reductase (AR) and sorbitol dehydrogenase (SDH).
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: map04010 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19157822/ |
|||
Target ID: reactive species, •OH and ROO• Sources: https://www.ncbi.nlm.nih.gov/pubmed/21995683/ |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Preventing | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Protective effects of cysteine analogues on acute myocardial ischemia: novel modulators of endogenous H(2)S production. | 2010-05-15 |
|
| Antioxidant strategy to rescue synaptosomes from oxidative damage and energy failure in neurotoxic models in rats: protective role of S-allylcysteine. | 2010-01 |
|
| S-allylcysteine modulates the expression of E-cadherin and inhibits the malignant progression of human oral cancer. | 2009-12 |
|
| A gas chromatography-mass spectrometry method for the quantitation of N-nitrosoproline and N-acetyl-S-allylcysteine in human urine: application to a study of the effects of garlic consumption on nitrosation. | 2009-11-15 |
|
| S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway. | 2009-08 |
|
| S-allylcysteine attenuates renal injury by altering the expressions of iNOS and matrix metallo proteinase-2 during cyclosporine-induced nephrotoxicity in Wistar rats. | 2009-08 |
|
| Enabling olefin metathesis on proteins: chemical methods for installation of S-allyl cysteine. | 2009-07-07 |
|
| Protein carbonylation in THP-1 cells induced by cigarette smoke extract via a copper-catalyzed pathway. | 2009-07 |
|
| S-allyl L-cysteine diminishes cerebral ischemia-induced mitochondrial dysfunctions in hippocampus. | 2009-04-10 |
|
| Preventive effect of S-allylcysteine on membrane-bound enzymes and glycoproteins in normal and isoproterenol-induced cardiac toxicity in male Wistar rats. | 2008-12 |
|
| Purification and characterization of flavin-containing monooxygenase isoform 3 from rat kidney microsomes. | 2008-12 |
|
| Protective effect of S-allylcysteine against cyclophosphamide-induced bladder hemorrhagic cystitis in mice. | 2008-11 |
|
| Alleviative effects of s-allyl cysteine and s-ethyl cysteine on MCD diet-induced hepatotoxicity in mice. | 2008-11 |
|
| Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds. | 2008-10-08 |
|
| Lipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: protective role of S-allylcysteine. | 2008-10 |
|
| Chromium (VI)-induced oxidative stress and apoptosis is reduced by garlic and its derivative S-allylcysteine through the activation of Nrf2 in the hepatocytes of Wistar rats. | 2008-10 |
|
| Abeta mediated diminution of MTT reduction--an artefact of single cell culture? | 2008-09-18 |
|
| Allyl sulfides are privileged substrates in aqueous cross-metathesis: application to site-selective protein modification. | 2008-07-30 |
|
| S-allylcysteine ameliorates ischemia and reperfusion induced renal damage. | 2008-06 |
|
| Antioxidant and iron-binding properties of curcumin, capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate. | 2008-05-14 |
|
| S-Allylcysteine reduces breast tumor cell adhesion and invasion. | 2008-03-07 |
|
| Cytoplasmic calcium mediates oxidative damage in an excitotoxic /energetic deficit synergic model in rats. | 2008-03 |
|
| Prevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by S-allylcysteine. | 2008-03 |
|
| Naringenin reduces tumor size and weight lost in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. | 2008-02 |
|
| Anti-amyloidogenic activity of S-allyl-L-cysteine and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro. | 2007-12-18 |
|
| Hypoglycemic effect of aqueous shallot and garlic extracts in rats with fructose-induced insulin resistance. | 2007-11 |
|
| Role of garlic in the prevention of ischemia-reperfusion injury. | 2007-11 |
|
| Hydrogen sulfide preconditioning by garlic when it starts to smell. | 2007-11 |
|
| S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway. | 2007-11 |
|
| Renoprotective and antihypertensive effects of S-allylcysteine in 5/6 nephrectomized rats. | 2007-11 |
|
| S-allylcysteine scavenges singlet oxygen and hypochlorous acid and protects LLC-PK(1) cells of potassium dichromate-induced toxicity. | 2007-10 |
|
| Protective and alleviative effects from 4 cysteine-containing compounds on ethanol-induced acute liver injury through suppression of oxidation and inflammation. | 2007-09 |
|
| Amyloid beta-protein potentiates tunicamycin-induced neuronal death in organotypic hippocampal slice cultures. | 2007-07-13 |
|
| Role of caspase-12 in amyloid beta-peptide-induced toxicity in organotypic hippocampal slices cultured for long periods. | 2007-05 |
|
| Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts. | 2007-04-30 |
|
| S-allyl cysteine prevents CCl(4)-induced acute liver injury in rats. | 2007-04 |
|
| S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions. | 2007-04 |
|
| Effect of heating on peroxynitrite scavenging capacity of garlic. | 2007-04 |
|
| S-allylcysteine ameliorates isoproterenol-induced cardiac toxicity in rats by stabilizing cardiac mitochondrial and lysosomal enzymes. | 2007-02-13 |
|
| Effect of aged garlic extract on APP processing and tau phosphorylation in Alzheimer's transgenic model Tg2576. | 2006-12-06 |
|
| A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression. | 2006-11 |
|
| Increased expression of heat shock protein 72 protects renal proximal tubular cells from gentamicin-induced injury. | 2006-10 |
|
| Structure-activity relationship of neuroprotective and reactive oxygen species scavenging activities for allium organosulfur compounds. | 2006-09-06 |
|
| S-Allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity, early markers of oxidative stress and mitochondrial dysfunction. | 2006-09 |
|
| S-Allyl-L-cysteine attenuates cerebral ischemic injury by scavenging peroxynitrite and inhibiting the activity of extracellular signal-regulated kinase. | 2006-08 |
|
| Dietary S-allyl-L-cysteine reduces mortality with decreased incidence of stroke and behavioral changes in stroke-prone spontaneously hypertensive rats. | 2006-08 |
|
| Preventive effect of S-allylcysteine on lipid peroxides and antioxidants in normal and isoproterenol-induced cardiotoxicity in rats: a histopathological study. | 2006-07-05 |
|
| N-acetylcysteine selectively protects cerebellar granule cells from 4-hydroxynonenal-induced cell death. | 2006-07 |
|
| The antioxidant properties of garlic compounds: allyl cysteine, alliin, allicin, and allyl disulfide. | 2006 |
|
| Chemoprotection against N-methyl-n'-nitro-N-nitrosoguanidine-induced oxidative stress by s-allylcysteine, a garlic constituent, in wistar rats. | 2003 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27373435
in rats: Diabetes was induced in male albino Wistar rats by intraperitoneal administration of STZ (55 mg kg-1 bw-1) and NA (110 mg kg-1 bw-1). S-allylcysteine (SAC) (150 mg kg-1 bw-1) was orally administered to the rats with diabetes for 45 days to assess its effects on blood glucose, insulin, insulin resistance, glycated hemoglobin, aldose reductase (AR), sorbitol dehydrogenase (SDH), sorbitol, fructose, thiobarbituric acid-reactive substances (TBARS), hydroperoxide, hemoglobin and glutathione (GSH).
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24362328
S-allylcysteine (SAC) suppressed proliferation and induced apoptosis in human ovarian cancer cells in vitro. SAC (1-100 mmol/L) inhibited the proliferation of A2780 cells in dose- and time-dependent manners (the IC50 value was approximately 25 mmol/L at 48 h, and less than 6.25 mmol/L at 96 h). Furthermore, SAC dose-dependently inhibited the colony formation of A2780 cells. Treatment of A2780 cells with SAC resulted in G1/S phase arrest and induced apoptosis, accompanied by decreased expression of pro-caspase-3, Parp-1 and Bcl-2, and increased expression of active caspase-3 and Bax. SAC treatment significantly reduced the migration of A2780 cells, and markedly decreased the protein expression of Wnt5a, p-AKT and c-Jun, which were the key proteins involved in proliferation and metastasis.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:41:26 GMT 2025
by
admin
on
Mon Mar 31 19:41:26 GMT 2025
|
| Record UNII |
81R3X99M15
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
JECFA EVALUATION |
S-ALLYL-L-CYSTEINE
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
||
|
NCI_THESAURUS |
C68520
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
||
|
NCI_THESAURUS |
C275
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
||
|
DSLD |
4106 (Number of products:1)
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
S-Allylcysteine
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
PRIMARY | |||
|
C63658
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
PRIMARY | |||
|
74077
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
PRIMARY | |||
|
1696
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
PRIMARY | |||
|
1013057
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
PRIMARY | |||
|
96449
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
PRIMARY | |||
|
DTXSID20894862
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
PRIMARY | |||
|
21593-77-1
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
PRIMARY | |||
|
C065299
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
PRIMARY | |||
|
81R3X99M15
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
PRIMARY | |||
|
9793905
Created by
admin on Mon Mar 31 19:41:26 GMT 2025 , Edited by admin on Mon Mar 31 19:41:26 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |